125 related articles for article (PubMed ID: 9865336)
1. Allogeneic and xenogeneic vascular injury and protection.
Pober JS; Schechner JS; Murray AG; Sultan P; Kirkiles N; Tereb D; Wilson J; McNiff JM; Askenase PW; Tellides G; Lorber MI
Transplant Proc; 1998 Dec; 30(8):4168-9. PubMed ID: 9865336
[No Abstract] [Full Text] [Related]
2. Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection.
Fukuzawa M; Okada A
Transplant Proc; 1994 Apr; 26(2):972-4. PubMed ID: 7513483
[No Abstract] [Full Text] [Related]
3. Xenogeneic (bovine) peripheral blood leukocytes engrafted into severe combined immunodeficient mice retain primary immune function.
Greenwood JD; Croy BA; Trout DR; Wilcock BP
Vet Immunol Immunopathol; 1997 Oct; 59(1-2):93-112. PubMed ID: 9437828
[TBL] [Abstract][Full Text] [Related]
4. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.
Murray AG; Schechner JS; Epperson DE; Sultan P; McNiff JM; Hughes CC; Lorber MI; Askenase PW; Pober JS
Am J Pathol; 1998 Aug; 153(2):627-38. PubMed ID: 9708821
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the human anti-pig cellular immune response using the Hu-scid mouse-porcine skin graft model.
Moss A; Fryer JP; Leventhal JR; Simone P; Chen S; Reinsmoen N; Matas AJ
Transplant Proc; 1994 Jun; 26(3):1209. PubMed ID: 8029889
[No Abstract] [Full Text] [Related]
6. CD8+ T lymphocytes account for acute accelerated allograft rejection in the rag mouse model.
Yoshimura R; Wada S; Nakatani T; Tsujino T; Yamamoto K; Kishimoto T; Ohyama A; Chargui J; Touraine JL
Transplant Proc; 1998 Nov; 30(7):2952. PubMed ID: 9838301
[No Abstract] [Full Text] [Related]
7. Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection.
Fox A; Mountford J; Braakhuis A; Harrison LC
J Immunol; 2001 Feb; 166(3):2133-40. PubMed ID: 11160265
[TBL] [Abstract][Full Text] [Related]
8. In vivo models of inflammation: immune rejection and skin transplantation in vivo.
Binet I; Wood KJ
Methods Mol Biol; 2003; 225():239-48. PubMed ID: 12769492
[No Abstract] [Full Text] [Related]
9. A new murine model of islet xenograft rejection: graft destruction is dependent on a major histocompatibility-specific interaction between T-cells and macrophages.
Schmidt P; Krook H; Maeda A; Korsgren O; Benda B
Diabetes; 2003 May; 52(5):1111-8. PubMed ID: 12716740
[TBL] [Abstract][Full Text] [Related]
10. Antisense deoxyoligonucleotides or antibodies to murine MD-1 inhibit rejection of allogeneic and xenogeneic skin grafts in C3H mice.
Hadidi S; Chen Z; Phillips J; Yu K; Gorczynski RM
Transplantation; 2002 Jun; 73(11):1771-9. PubMed ID: 12085000
[TBL] [Abstract][Full Text] [Related]
11. Regulation of B- and T-cell mediated xenogeneic transplant rejection by interleukin 12.
Hosiawa KA; Wang H; DeVries ME; Garcia B; Jiang J; Zhou D; Cameron MJ; Zhong R; Kelvin DJ
Transplantation; 2006 Jan; 81(2):265-72. PubMed ID: 16436971
[TBL] [Abstract][Full Text] [Related]
12. Skin allografts--lymph veiled (dendritic) cells are responsible for initiation of rejection in canine skin/SCID mouse chimera model.
Galkowska H; Olszewski WL; Moscicka M; Cybulska E; Ziolkowska A; Wojewodzka U; Mijal J
Ann Transplant; 1999; 4(3-4):5-10. PubMed ID: 10853773
[TBL] [Abstract][Full Text] [Related]
13. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice.
Valujskikh A; Matesic D; Gilliam A; Anthony D; Haqqi TM; Heeger PS
J Clin Invest; 1998 Mar; 101(6):1398-407. PubMed ID: 9502782
[TBL] [Abstract][Full Text] [Related]
14. Skin allografts-host cutaneous veiled cells initiate rejection reaction by indirect pathway of allorecognition.
Galkowska H; Moscicka M; Cybulska E; Wojewodzka U; Mijal J; Olszewski WL
Transplant Proc; 2001; 33(1-2):627-30. PubMed ID: 11266990
[No Abstract] [Full Text] [Related]
15. Immunopathology of liver allografts and xenografts in nonhuman primates.
Donato MF; Arosio E; Berti E; Gatti S; Piazzini A; Colledan M; Rossi G; Fassati LR; Galmarini D; Gridelli B
Transplant Proc; 1993 Feb; 25(1 Pt 2):850-5. PubMed ID: 8442246
[No Abstract] [Full Text] [Related]
16. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
Erdag G; Morgan JR
Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
[TBL] [Abstract][Full Text] [Related]
17. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.
Kawamura T; Niguma T; Fechner JH; Wolber R; Beeskau MA; Hullett DA; Sollinger HW; Burlingham WJ
Transplantation; 1992 Mar; 53(3):659-65. PubMed ID: 1549862
[TBL] [Abstract][Full Text] [Related]
18. Immunologic studies in primates undergoing concordant xenotransplantation as a bridge allotransplantation.
Shah AS; Itescu S; O'Hair DP; Tugulea S; Kwiatkowski PA; Liu Z; Platt JL; Rose EA; Suciu-Foca N; Michler RE
Transplant Proc; 1996 Apr; 28(2):745-6. PubMed ID: 8623377
[No Abstract] [Full Text] [Related]
19. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
Erdag G; Morgan JR
Cell Transplant; 2004; 13(6):701-12. PubMed ID: 15648740
[TBL] [Abstract][Full Text] [Related]
20. Xenogeneic cellular response of human lymphocytes to porcine lymphocytes and isolated porcine pancreatic islets.
Heiser A; Ulrichs K; Eckstein V; Müller-Ruchholtz W
Transplant Proc; 1992 Dec; 24(6):2881-2. PubMed ID: 1465982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
